These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 1215372)
41. [Level of isoniazid labeled with C-14 in the tissue of animals infected with tuberculosis administered insulin]. Lukjan Z; Rogowski F; Oleński J Gruzlica; 1969 Oct; 37(10):893-9. PubMed ID: 5366980 [No Abstract] [Full Text] [Related]
42. [Combined action of histones and anibacterial agents in vitro and in vivo--potentiation of the effect of tubazide]. Ashmarin IN; Vavilin GI; Vishnevskiĭ BI; Gaber IE; Perel'man AE Dokl Akad Nauk SSSR; 1971 Nov; 201(2):477-9. PubMed ID: 5131107 [No Abstract] [Full Text] [Related]
43. [Antitubercular activity of prothionamide-isoiazid combination. Experimental study]. Arzu G; De Santis G; Ginesu F G Ital Chemioter; 1967; 14(1):58-64. PubMed ID: 5622726 [No Abstract] [Full Text] [Related]
44. [Experimental study of a biphasic treatment (RMP followed by INH) in tuberculosis in guinea pigs]. Algeorge G; Petre A; Rudescu D Ftiziologia; 1973; 22(3):295-304. PubMed ID: 4576115 [No Abstract] [Full Text] [Related]
45. [Significance of decalcification in the treatment of tuberculosis. 8. Studies on the effect of decalcification on the course of tuberculosis caused by INH-resistant bacilli]. Giza T; Hanicka M; Herman T; Jelonek A; Kurdzielewicz J; Rembiesowa H; Rudnik J; Wójciak W Gruzlica; 1968 Jun; 36(6):545-50. PubMed ID: 4970099 [No Abstract] [Full Text] [Related]
46. Isoniazid prophylaxis in experimental tuberculosis. Comparison of single versus multiple daily doses. Bjerkedal T; Palmer CE Scand J Respir Dis; 1966; 47(2):131-49. PubMed ID: 4957691 [No Abstract] [Full Text] [Related]
47. [Serological and pathomorphological aspects of the autoimmunization process in experimental tuberculosis in guinea pigs exposed to fractionated gamma-irradition and treated with isoniazid]. Vulchanov Vkh ; Vasilev VN; Kekhaiov IR Izv Mikrobiol Inst (Sofiia); 1972; 23():101-9. PubMed ID: 4197600 [No Abstract] [Full Text] [Related]
48. [Effect of different isoniazid concentrations on the Mycobacterium tuberculosis variant highly resistant to the preparation]. Bondarev IM; Dolgaia TM Probl Tuberk; 1980 Aug; (8):65-9. PubMed ID: 6773048 [No Abstract] [Full Text] [Related]
49. [Rifampicin and isoniazid in the intermittent treatment of experimental tuberculosis in guinea-pigs]. Daddi G; Lucchesi M; Mancini P Ann Ist Carlo Forlanini; 1969; 29(1):35-40. PubMed ID: 5405839 [No Abstract] [Full Text] [Related]
50. Hepatic mixed function oxidase induction during rifampicin/isoniazid therapy in Indian vegetarians. Perry W; Jenkins MV Int J Clin Pharmacol Ther Toxicol; 1986 Jul; 24(7):344-8. PubMed ID: 3733284 [TBL] [Abstract][Full Text] [Related]
51. [Splenin therapy of patients with acute infectious hepatitis]. Verzhkhovskaia AA Vrach Delo; 1966 Mar; 3():106-10. PubMed ID: 5990007 [No Abstract] [Full Text] [Related]
52. [On the comparative effectiveness of rifampicin and INI treatment in guinea pigs inoculated with repeated microdoses of bacilli]. Fabbrocini V Arch Tisiol Mal Appar Respir; 1968 Jun; 23(6):435-40. PubMed ID: 4984548 [No Abstract] [Full Text] [Related]
53. [Role of anabolic steroid hormones in the treatment of experimental tuberculosis]. Kashenov T Sov Zdravookhr Kirg; 1972; 3():13-5. PubMed ID: 4666412 [No Abstract] [Full Text] [Related]
54. Rationale and experimental data in support of the use of a fixed-triple combination of isoniazid, rifampicin and pyrazinamide in the chemotherapy of tuberculosis. Acocella G G Ital Chemioter; 1987; 34(1-3):3-5. PubMed ID: 3504412 [No Abstract] [Full Text] [Related]
55. [Experimental evidence for Mycobacterium tuberculosis persistence in M. tuberculosis-infected H37RV mice in the treatment with 3 first-line drugs (rifampicin, isoniazid, pyrazinamide)]. Smirnova TG; Chernousova LN; Andreevskaia SN; Nikolaeva GM Probl Tuberk Bolezn Legk; 2004; (3):32-7. PubMed ID: 15338898 [TBL] [Abstract][Full Text] [Related]
57. [Effect of parmidin on the course of tuberculosis under isoniazid therapy]. Solov'eva IP; Makinskiĭ AI Vrach Delo; 1984 Sep; (9):70-3. PubMed ID: 6390963 [No Abstract] [Full Text] [Related]
58. [Various experimental diseases induced in guinea pigs by the historical Institut Pasteur BCG strain and by the B-1 positive catalase strain. Study of the viability of the inoculated bacteria]. Levaditi JC; Kosloff-Sénéchal F; Balouet G; Augier J Ann Inst Pasteur (Paris); 1968 Dec; 115(6):1053-62. PubMed ID: 4890580 [No Abstract] [Full Text] [Related]
59. [Research on the protective action of rifampicin administered intermittently in experimental tuberculosis in guinea pigs]. Algeorge G; Sibilla S; Rudesco D Ann Pediatr (Paris); 1970 Oct; 17(10):674. PubMed ID: 5475418 [No Abstract] [Full Text] [Related]
60. [On antitubercular prevention with isoniazid]. Omodei Zorini A Ann Ist Carlo Forlanini; 1968; 28(3):203-14. PubMed ID: 5738647 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]